HEADER HYDROLASE 12-MAY-09 2WIL TITLE AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TITLE 2 TA5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINESTERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 29-557; COMPND 5 SYNONYM: ACYLCHOLINE ACYLHYDROLASE, BUTYRYLCHOLINE ESTERASE, CHOLINE COMPND 6 ESTERASE II, PSEUDOCHOLINESTERASE; COMPND 7 EC: 3.1.1.8; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: S198 IS PHOSPHORAMIDYLATED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: K1; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGS KEYWDS AGING, HYDROLASE, INHIBITION, POLYMORPHISM, GLYCOPROTEIN, SERINE KEYWDS 2 ESTERASE, DISEASE MUTATION EXPDTA X-RAY DIFFRACTION AUTHOR E.CARLETTI,N.AURBEK,E.GILLON,M.LOIODICE,Y.NICOLET,J.FONTECILLA, AUTHOR 2 P.MASSON,H.THIERMANN,F.NACHON,F.WOREK REVDAT 8 13-DEC-23 2WIL 1 REMARK HETSYN LINK REVDAT 7 29-JUL-20 2WIL 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 06-FEB-19 2WIL 1 REMARK REVDAT 5 30-JAN-19 2WIL 1 REMARK REVDAT 4 28-FEB-18 2WIL 1 SOURCE REMARK REVDAT 3 27-APR-11 2WIL 1 KEYWDS JRNL REMARK FORMUL REVDAT 3 2 1 SITE REVDAT 2 02-JUN-09 2WIL 1 REVDAT REVDAT 1 26-MAY-09 2WIL 0 JRNL AUTH E.CARLETTI,N.AURBEK,E.GILLON,M.LOIODICE,Y.NICOLET, JRNL AUTH 2 J.FONTECILLA,P.MASSON,H.THIERMANN,F.NACHON,F.WOREK JRNL TITL STRUCTURE-ACTIVITY ANALYSIS OF AGING AND REACTIVATION OF JRNL TITL 2 HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY ANALOGUES OF TABUN JRNL REF BIOCHEM.J. V. 421 97 2009 JRNL REFN ISSN 0264-6021 JRNL PMID 19368529 JRNL DOI 10.1042/BJ20090091 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0069 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 28167 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.200 REMARK 3 FREE R VALUE TEST SET COUNT : 937 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.18 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2026 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.08 REMARK 3 BIN R VALUE (WORKING SET) : 0.3520 REMARK 3 BIN FREE R VALUE SET COUNT : 64 REMARK 3 BIN FREE R VALUE : 0.4160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 264 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.445 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.336 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.693 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8916 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12142 ; 1.415 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1056 ; 5.988 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 403 ;35.627 ;24.020 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1400 ;19.034 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;17.531 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1327 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6734 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5247 ; 0.598 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8475 ; 1.146 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3669 ; 1.358 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3664 ; 2.480 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1531 A 1542 1 REMARK 3 1 B 1531 B 1539 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 118 ; 0.03 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 B (A): 118 ; 0.03 ; 0.05 REMARK 3 TIGHT THERMAL 1 A (A**2): 118 ; 0.35 ; 0.50 REMARK 3 TIGHT THERMAL 1 B (A**2): 118 ; 0.35 ; 0.50 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 2 A 529 1 REMARK 3 1 B 4 B 529 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 A (A): 4185 ; 0.04 ; 0.05 REMARK 3 TIGHT POSITIONAL 2 B (A): 4185 ; 0.04 ; 0.05 REMARK 3 TIGHT THERMAL 2 A (A**2): 4185 ; 0.11 ; 0.50 REMARK 3 TIGHT THERMAL 2 B (A**2): 4185 ; 0.11 ; 0.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2WIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1290039791. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9395 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28167 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: XDS REMARK 200 STARTING MODEL: PDB ENTRY 1P0I REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1 M AMMONIUM SULFATE, 100 MM MES PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 75.17500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 75.17500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 75.17500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 75.17500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 75.17500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 75.17500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 75.17500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 75.17500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 34890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 158820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -150.35000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 -75.17500 REMARK 350 BIOMT2 3 -1.000000 0.000000 0.000000 -75.17500 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 -1.000000 0.000000 -75.17500 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 75.17500 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 728 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 45 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 509 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 45 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 509 TO GLN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 ASP A 378 REMARK 465 ASP A 379 REMARK 465 GLU B 1 REMARK 465 ASP B 2 REMARK 465 ASP B 3 REMARK 465 ASP B 378 REMARK 465 ASP B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 486 CG OD1 ND2 REMARK 470 ASN B 486 CG OD1 ND2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 TYR A 282 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 380 O HOH A 701 2.15 REMARK 500 O LYS B 355 O HOH B 701 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 282 CB TYR A 282 CG -0.171 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 282 CB - CG - CD2 ANGL. DEV. = 7.4 DEGREES REMARK 500 TYR A 282 CB - CG - CD1 ANGL. DEV. = -7.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 3 104.71 37.68 REMARK 500 LYS A 9 5.21 -59.47 REMARK 500 ASP A 54 -167.35 98.86 REMARK 500 ALA A 58 72.72 -104.26 REMARK 500 GLN A 67 161.25 178.13 REMARK 500 CYS A 92 12.32 -146.90 REMARK 500 LYS A 103 124.72 -35.36 REMARK 500 PHE A 118 10.51 57.93 REMARK 500 PHE A 153 16.89 -141.32 REMARK 500 SER A 198 -120.62 44.36 REMARK 500 HIS A 214 -54.35 -29.15 REMARK 500 SER A 224 68.70 37.54 REMARK 500 SER A 226 147.43 -171.59 REMARK 500 ASN A 228 4.90 -68.89 REMARK 500 GLU A 255 -63.92 -107.14 REMARK 500 PRO A 269 -51.79 -28.97 REMARK 500 ASP A 297 -82.80 -113.30 REMARK 500 ASP A 301 159.10 173.86 REMARK 500 GLN A 311 66.06 -103.17 REMARK 500 ASN A 342 22.30 -74.21 REMARK 500 SER A 362 153.11 -34.43 REMARK 500 THR A 374 44.03 -106.22 REMARK 500 ASP A 375 79.53 -101.21 REMARK 500 PHE A 398 -69.00 -135.20 REMARK 500 VAL A 436 89.28 -63.77 REMARK 500 PRO A 449 0.12 -66.20 REMARK 500 ARG A 453 70.83 -64.54 REMARK 500 ASP A 454 -16.60 -152.48 REMARK 500 PRO A 480 43.92 -89.35 REMARK 500 ASN A 485 49.83 -98.43 REMARK 500 GLU A 506 -107.25 -73.93 REMARK 500 LYS B 9 6.01 -59.74 REMARK 500 PHE B 28 79.42 -110.86 REMARK 500 ASP B 54 -167.48 99.05 REMARK 500 ALA B 58 73.38 -103.95 REMARK 500 GLN B 67 157.59 176.04 REMARK 500 MET B 81 -17.95 -49.37 REMARK 500 LYS B 103 125.47 -33.54 REMARK 500 SER B 198 -124.57 39.89 REMARK 500 SER B 224 77.53 26.93 REMARK 500 SER B 226 146.06 -171.84 REMARK 500 GLU B 255 -67.15 -108.19 REMARK 500 PRO B 269 -55.62 -28.89 REMARK 500 PRO B 285 -17.02 -47.69 REMARK 500 ASP B 297 -77.14 -114.69 REMARK 500 ASP B 301 160.07 170.19 REMARK 500 GLN B 311 66.96 -106.26 REMARK 500 ASN B 342 22.60 -74.98 REMARK 500 SER B 362 154.34 -37.37 REMARK 500 THR B 374 46.63 -106.23 REMARK 500 REMARK 500 THIS ENTRY HAS 60 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EHQ RELATED DB: PDB REMARK 900 MODEL OF (+)-COCAINE-BOUND BCHE COMPLEX REMARK 900 RELATED ID: 2J4C RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2 REMARK 900 RELATED ID: 1P0Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE REMARK 900 RELATED ID: 2WIK RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA6 REMARK 900 RELATED ID: 1KCJ RELATED DB: PDB REMARK 900 MODEL OF (-)-COCAINE-BOUND (-)-COCAINE HYDROLASE COMPLEX REMARK 900 RELATED ID: 1P0P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH THE SUBSTRATE ANALOGBUTYRYLTHIOCHOLINE REMARK 900 RELATED ID: 2WID RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA1 REMARK 900 RELATED ID: 1XLU RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO- FLUORIDATE (DFP) REMARK 900 INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING REMARK 900 RELATED ID: 2WIJ RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA5 REMARK 900 RELATED ID: 1XLV RELATED DB: PDB REMARK 900 ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINEDBY REMARK 900 REACTION WITH ECHOTHIOPHATE REMARK 900 RELATED ID: 1EHO RELATED DB: PDB REMARK 900 MODEL OF (-)-COCAINE-BOUND BCHE COMPLEX. REMARK 900 RELATED ID: 2WIF RELATED DB: PDB REMARK 900 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA1 REMARK 900 RELATED ID: 1P0M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE INCOMPLEX WITH A REMARK 900 CHOLINE MOLECULE REMARK 900 RELATED ID: 1XLW RELATED DB: PDB REMARK 900 DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REMARK 900 REACTION WITH ECHOTHIOPHATE REMARK 900 RELATED ID: 1P0I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE REMARK 900 RELATED ID: 2WIG RELATED DB: PDB REMARK 900 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN REMARK 900 ANALOGUE TA4 DBREF 2WIL A 1 529 UNP P06276 CHLE_HUMAN 29 557 DBREF 2WIL B 1 529 UNP P06276 CHLE_HUMAN 29 557 SEQADV 2WIL GLN A 17 UNP P06276 ASN 45 ENGINEERED MUTATION SEQADV 2WIL GLN A 481 UNP P06276 ASN 509 ENGINEERED MUTATION SEQADV 2WIL GLN B 17 UNP P06276 ASN 45 ENGINEERED MUTATION SEQADV 2WIL GLN B 481 UNP P06276 ASN 509 ENGINEERED MUTATION SEQRES 1 A 529 GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY LYS VAL SEQRES 2 A 529 ARG GLY MET GLN LEU THR VAL PHE GLY GLY THR VAL THR SEQRES 3 A 529 ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO LEU GLY SEQRES 4 A 529 ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR LYS TRP SEQRES 5 A 529 SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SER CYS SEQRES 6 A 529 CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE HIS GLY SEQRES 7 A 529 SER GLU MET TRP ASN PRO ASN THR ASP LEU SER GLU ASP SEQRES 8 A 529 CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO LYS PRO SEQRES 9 A 529 LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY GLY GLY SEQRES 10 A 529 PHE GLN THR GLY THR SER SER LEU HIS VAL TYR ASP GLY SEQRES 11 A 529 LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL VAL SER SEQRES 12 A 529 MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU ALA LEU SEQRES 13 A 529 PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY LEU PHE SEQRES 14 A 529 ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS ASN ILE SEQRES 15 A 529 ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR LEU PHE SEQRES 16 A 529 GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU HIS LEU SEQRES 17 A 529 LEU SER PRO GLY SER HIS SER LEU PHE THR ARG ALA ILE SEQRES 18 A 529 LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA VAL THR SEQRES 19 A 529 SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN LEU ALA SEQRES 20 A 529 LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR GLU ILE SEQRES 21 A 529 ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU ILE LEU SEQRES 22 A 529 LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR PRO LEU SEQRES 23 A 529 SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP PHE LEU SEQRES 24 A 529 THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY GLN PHE SEQRES 25 A 529 LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS ASP GLU SEQRES 26 A 529 GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY PHE SER SEQRES 27 A 529 LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU PHE GLN SEQRES 28 A 529 GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER GLU PHE SEQRES 29 A 529 GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP TRP VAL SEQRES 30 A 529 ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA LEU GLY SEQRES 31 A 529 ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO ALA LEU SEQRES 32 A 529 GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN ASN ALA SEQRES 33 A 529 PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS LEU PRO SEQRES 34 A 529 TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR GLU ILE SEQRES 35 A 529 GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG ASP ASN SEQRES 36 A 529 TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER ILE VAL SEQRES 37 A 529 LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN PRO GLN SEQRES 38 A 529 GLU THR GLN ASN ASN SER THR SER TRP PRO VAL PHE LYS SEQRES 39 A 529 SER THR GLU GLN LYS TYR LEU THR LEU ASN THR GLU SER SEQRES 40 A 529 THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN CYS ARG SEQRES 41 A 529 PHE TRP THR SER PHE PHE PRO LYS VAL SEQRES 1 B 529 GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY LYS VAL SEQRES 2 B 529 ARG GLY MET GLN LEU THR VAL PHE GLY GLY THR VAL THR SEQRES 3 B 529 ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO LEU GLY SEQRES 4 B 529 ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR LYS TRP SEQRES 5 B 529 SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SER CYS SEQRES 6 B 529 CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE HIS GLY SEQRES 7 B 529 SER GLU MET TRP ASN PRO ASN THR ASP LEU SER GLU ASP SEQRES 8 B 529 CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO LYS PRO SEQRES 9 B 529 LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY GLY GLY SEQRES 10 B 529 PHE GLN THR GLY THR SER SER LEU HIS VAL TYR ASP GLY SEQRES 11 B 529 LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL VAL SER SEQRES 12 B 529 MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU ALA LEU SEQRES 13 B 529 PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY LEU PHE SEQRES 14 B 529 ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS ASN ILE SEQRES 15 B 529 ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR LEU PHE SEQRES 16 B 529 GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU HIS LEU SEQRES 17 B 529 LEU SER PRO GLY SER HIS SER LEU PHE THR ARG ALA ILE SEQRES 18 B 529 LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA VAL THR SEQRES 19 B 529 SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN LEU ALA SEQRES 20 B 529 LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR GLU ILE SEQRES 21 B 529 ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU ILE LEU SEQRES 22 B 529 LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR PRO LEU SEQRES 23 B 529 SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP PHE LEU SEQRES 24 B 529 THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY GLN PHE SEQRES 25 B 529 LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS ASP GLU SEQRES 26 B 529 GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY PHE SER SEQRES 27 B 529 LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU PHE GLN SEQRES 28 B 529 GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER GLU PHE SEQRES 29 B 529 GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP TRP VAL SEQRES 30 B 529 ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA LEU GLY SEQRES 31 B 529 ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO ALA LEU SEQRES 32 B 529 GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN ASN ALA SEQRES 33 B 529 PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS LEU PRO SEQRES 34 B 529 TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR GLU ILE SEQRES 35 B 529 GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG ASP ASN SEQRES 36 B 529 TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER ILE VAL SEQRES 37 B 529 LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN PRO GLN SEQRES 38 B 529 GLU THR GLN ASN ASN SER THR SER TRP PRO VAL PHE LYS SEQRES 39 B 529 SER THR GLU GLN LYS TYR LEU THR LEU ASN THR GLU SER SEQRES 40 B 529 THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN CYS ARG SEQRES 41 B 529 PHE TRP THR SER PHE PHE PRO LYS VAL MODRES 2WIL ASN A 57 ASN GLYCOSYLATION SITE MODRES 2WIL ASN A 106 ASN GLYCOSYLATION SITE MODRES 2WIL ASN A 241 ASN GLYCOSYLATION SITE MODRES 2WIL ASN A 341 ASN GLYCOSYLATION SITE MODRES 2WIL ASN A 485 ASN GLYCOSYLATION SITE MODRES 2WIL ASN B 57 ASN GLYCOSYLATION SITE MODRES 2WIL ASN B 106 ASN GLYCOSYLATION SITE MODRES 2WIL ASN B 241 ASN GLYCOSYLATION SITE MODRES 2WIL ASN B 341 ASN GLYCOSYLATION SITE MODRES 2WIL ASN B 485 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET FUC C 3 10 HET NAG D 1 14 HET NAG D 2 14 HET FUC D 3 10 HET NAG E 1 14 HET NAG E 2 14 HET FUC E 3 10 HET NAG F 1 14 HET NAG F 2 14 HET FUC F 3 10 HET TCX A 601 6 HET NAG A 608 14 HET NAG A 609 14 HET NAG A 610 14 HET SO4 A 611 5 HET SO4 A 612 5 HET CL A 613 1 HET TCX B 601 6 HET NAG B 608 14 HET NAG B 609 14 HET NAG B 610 14 HET SO4 B 611 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM TCX ETHYLPHOSPHORAMIDIC ACID HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 14(C8 H15 N O6) FORMUL 3 FUC 4(C6 H12 O5) FORMUL 7 TCX 2(C2 H8 N O3 P) FORMUL 11 SO4 3(O4 S 2-) FORMUL 13 CL CL 1- FORMUL 19 HOH *137(H2 O) HELIX 1 AA1 LEU A 38 ARG A 42 5 5 HELIX 2 AA2 PHE A 76 MET A 81 1 6 HELIX 3 AA3 LEU A 125 ASP A 129 5 5 HELIX 4 AA4 GLY A 130 ARG A 138 1 9 HELIX 5 AA5 VAL A 148 LEU A 154 1 7 HELIX 6 AA6 ASN A 165 ILE A 182 1 18 HELIX 7 AA7 ALA A 183 PHE A 185 5 3 HELIX 8 AA8 SER A 198 SER A 210 1 13 HELIX 9 AA9 SER A 210 SER A 215 1 6 HELIX 10 AB1 SER A 235 THR A 250 1 16 HELIX 11 AB2 ASN A 256 ARG A 265 1 10 HELIX 12 AB3 ASP A 268 ALA A 277 1 10 HELIX 13 AB4 MET A 302 LEU A 309 1 8 HELIX 14 AB5 GLY A 326 VAL A 331 1 6 HELIX 15 AB6 THR A 346 PHE A 358 1 13 HELIX 16 AB7 SER A 362 THR A 374 1 13 HELIX 17 AB8 GLU A 383 PHE A 398 1 16 HELIX 18 AB9 PHE A 398 GLU A 411 1 14 HELIX 19 AC1 PRO A 431 GLY A 435 5 5 HELIX 20 AC2 GLU A 441 PHE A 446 1 6 HELIX 21 AC3 GLY A 447 GLU A 451 5 5 HELIX 22 AC4 THR A 457 GLY A 478 1 22 HELIX 23 AC5 ARG A 515 SER A 524 1 10 HELIX 24 AC6 PHE A 525 VAL A 529 5 5 HELIX 25 AC7 LEU B 38 ARG B 42 5 5 HELIX 26 AC8 PHE B 76 MET B 81 1 6 HELIX 27 AC9 LEU B 125 ASP B 129 5 5 HELIX 28 AD1 GLY B 130 ARG B 138 1 9 HELIX 29 AD2 VAL B 148 LEU B 154 1 7 HELIX 30 AD3 ASN B 165 ILE B 182 1 18 HELIX 31 AD4 ALA B 183 PHE B 185 5 3 HELIX 32 AD5 SER B 198 SER B 210 1 13 HELIX 33 AD6 PRO B 211 PHE B 217 5 7 HELIX 34 AD7 SER B 235 THR B 250 1 16 HELIX 35 AD8 ASN B 256 ARG B 265 1 10 HELIX 36 AD9 ASP B 268 ALA B 277 1 10 HELIX 37 AE1 MET B 302 LEU B 309 1 8 HELIX 38 AE2 GLY B 326 VAL B 331 1 6 HELIX 39 AE3 THR B 346 PHE B 358 1 13 HELIX 40 AE4 SER B 362 THR B 374 1 13 HELIX 41 AE5 GLU B 383 PHE B 398 1 16 HELIX 42 AE6 PHE B 398 GLU B 411 1 14 HELIX 43 AE7 PRO B 431 GLY B 435 5 5 HELIX 44 AE8 GLU B 441 PHE B 446 1 6 HELIX 45 AE9 GLY B 447 GLU B 451 5 5 HELIX 46 AF1 THR B 457 GLY B 478 1 22 HELIX 47 AF2 ARG B 515 PHE B 525 1 11 HELIX 48 AF3 PHE B 526 VAL B 529 5 4 SHEET 1 AA1 3 ILE A 5 THR A 8 0 SHEET 2 AA1 3 GLY A 11 ARG A 14 -1 O VAL A 13 N ILE A 6 SHEET 3 AA1 3 ILE A 55 ASN A 57 1 O TRP A 56 N ARG A 14 SHEET 1 AA211 GLN A 17 THR A 19 0 SHEET 2 AA211 THR A 24 PRO A 32 -1 O VAL A 25 N LEU A 18 SHEET 3 AA211 TYR A 94 PRO A 100 -1 O VAL A 97 N PHE A 28 SHEET 4 AA211 ILE A 140 MET A 144 -1 O SER A 143 N ASN A 96 SHEET 5 AA211 ALA A 107 ILE A 113 1 N LEU A 110 O VAL A 142 SHEET 6 AA211 GLY A 187 GLU A 197 1 O ASN A 188 N ALA A 107 SHEET 7 AA211 ARG A 219 GLN A 223 1 O ARG A 219 N LEU A 194 SHEET 8 AA211 ILE A 317 ASN A 322 1 O LEU A 318 N LEU A 222 SHEET 9 AA211 ALA A 416 PHE A 421 1 O PHE A 421 N VAL A 321 SHEET 10 AA211 LYS A 499 LEU A 503 1 O LEU A 501 N PHE A 418 SHEET 11 AA211 ILE A 510 THR A 512 -1 O MET A 511 N TYR A 500 SHEET 1 AA3 3 ILE B 5 THR B 8 0 SHEET 2 AA3 3 GLY B 11 ARG B 14 -1 O GLY B 11 N THR B 8 SHEET 3 AA3 3 ILE B 55 ASN B 57 1 O TRP B 56 N LYS B 12 SHEET 1 AA411 GLN B 17 THR B 19 0 SHEET 2 AA411 THR B 24 PRO B 32 -1 O VAL B 25 N LEU B 18 SHEET 3 AA411 TYR B 94 ALA B 101 -1 O VAL B 97 N PHE B 28 SHEET 4 AA411 ILE B 140 MET B 144 -1 O SER B 143 N ASN B 96 SHEET 5 AA411 ALA B 107 ILE B 113 1 N LEU B 110 O VAL B 142 SHEET 6 AA411 GLY B 187 GLU B 197 1 O ASN B 188 N ALA B 107 SHEET 7 AA411 ARG B 219 GLN B 223 1 O ARG B 219 N LEU B 194 SHEET 8 AA411 ILE B 317 ASN B 322 1 O LEU B 318 N LEU B 222 SHEET 9 AA411 ALA B 416 PHE B 421 1 O PHE B 417 N VAL B 319 SHEET 10 AA411 LYS B 499 LEU B 503 1 O LEU B 501 N PHE B 418 SHEET 11 AA411 ILE B 510 THR B 512 -1 O MET B 511 N TYR B 500 SSBOND 1 CYS A 65 CYS A 92 1555 1555 2.02 SSBOND 2 CYS A 252 CYS A 263 1555 1555 2.04 SSBOND 3 CYS A 400 CYS A 519 1555 1555 2.06 SSBOND 4 CYS B 65 CYS B 92 1555 1555 2.05 SSBOND 5 CYS B 252 CYS B 263 1555 1555 2.04 SSBOND 6 CYS B 400 CYS B 519 1555 1555 2.06 LINK ND2 ASN A 57 C1 NAG A 609 1555 1555 1.48 LINK ND2 ASN A 106 C1 NAG A 608 1555 1555 1.46 LINK OG SER A 198 P TCX A 601 1555 1555 1.61 LINK ND2 ASN A 241 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN A 341 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 485 C1 NAG A 610 1555 1555 1.45 LINK ND2 ASN B 57 C1 NAG B 609 1555 1555 1.47 LINK ND2 ASN B 106 C1 NAG B 608 1555 1555 1.45 LINK OG SER B 198 P TCX B 601 1555 1555 1.61 LINK ND2 ASN B 241 C1 NAG E 1 1555 1555 1.46 LINK ND2 ASN B 341 C1 NAG F 1 1555 1555 1.46 LINK ND2 ASN B 485 C1 NAG B 610 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.46 LINK O6 NAG C 1 C1 FUC C 3 1555 1555 1.46 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O6 NAG D 1 C1 FUC D 3 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.46 LINK O6 NAG E 1 C1 FUC E 3 1555 1555 1.45 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.45 LINK O6 NAG F 1 C1 FUC F 3 1555 1555 1.45 CISPEP 1 ASP A 2 ASP A 3 0 11.34 CISPEP 2 ALA A 101 PRO A 102 0 9.15 CISPEP 3 ALA B 101 PRO B 102 0 9.03 CRYST1 150.350 150.350 139.430 90.00 90.00 90.00 P 4 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006651 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006651 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007172 0.00000